

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 9.99888483 |
| 2 | negative regulation of muscle hypertrophy (GO:0014741) | 9.97560115 |
| 3 | negative regulation of protein localization to cell surface (GO:2000009) | 9.69273910 |
| 4 | ribonucleoprotein complex disassembly (GO:0032988) | 9.60863757 |
| 5 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 9.16953422 |
| 6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 8.76694696 |
| 7 | membrane raft organization (GO:0031579) | 8.55283144 |
| 8 | negative regulation of organelle assembly (GO:1902116) | 8.34947364 |
| 9 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 8.34100425 |
| 10 | negative regulation of heart growth (GO:0061117) | 8.32731650 |
| 11 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 8.32731650 |
| 12 | organelle disassembly (GO:1903008) | 8.17945807 |
| 13 | negative regulation of monooxygenase activity (GO:0032769) | 7.44198699 |
| 14 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 7.25418497 |
| 15 | negative regulation of cell size (GO:0045792) | 7.14389516 |
| 16 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 7.07622914 |
| 17 | positive regulation of microtubule polymerization (GO:0031116) | 7.02261028 |
| 18 | positive regulation of myotube differentiation (GO:0010831) | 6.40950707 |
| 19 | regulation of action potential (GO:0098900) | 6.36825050 |
| 20 | regulation of p38MAPK cascade (GO:1900744) | 6.13435081 |
| 21 | negative regulation of cardiac muscle tissue development (GO:0055026) | 6.05301529 |
| 22 | membrane assembly (GO:0071709) | 6.03839045 |
| 23 | striated muscle atrophy (GO:0014891) | 5.75058150 |
| 24 | muscle cell cellular homeostasis (GO:0046716) | 5.70253451 |
| 25 | regulation of cardiac muscle cell differentiation (GO:2000725) | 5.36665249 |
| 26 | muscle atrophy (GO:0014889) | 5.30743350 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.19617251 |
| 28 | negative regulation of cell killing (GO:0031342) | 5.19617251 |
| 29 | primary alcohol catabolic process (GO:0034310) | 5.02419609 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91942305 |
| 31 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.87104196 |
| 32 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 4.80820430 |
| 33 | heart trabecula formation (GO:0060347) | 4.70563529 |
| 34 | cytoplasmic microtubule organization (GO:0031122) | 4.58101867 |
| 35 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 4.57497275 |
| 36 | postreplication repair (GO:0006301) | 4.55240151 |
| 37 | regulation of membrane repolarization (GO:0060306) | 4.50493465 |
| 38 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 4.44425116 |
| 39 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.39019893 |
| 40 | cardiac myofibril assembly (GO:0055003) | 4.38937930 |
| 41 | regulation of muscle hypertrophy (GO:0014743) | 4.37859012 |
| 42 | regulation of alkaline phosphatase activity (GO:0010692) | 4.35929466 |
| 43 | positive T cell selection (GO:0043368) | 4.33392466 |
| 44 | negative regulation of potassium ion transport (GO:0043267) | 4.21552874 |
| 45 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.20006407 |
| 46 | response to muscle activity (GO:0014850) | 4.19144259 |
| 47 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.11516614 |
| 48 | polyol biosynthetic process (GO:0046173) | 4.10579425 |
| 49 | lens fiber cell differentiation (GO:0070306) | 4.03773312 |
| 50 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 4.02782796 |
| 51 | myoblast fusion (GO:0007520) | 3.98031802 |
| 52 | negative regulation of oxidoreductase activity (GO:0051354) | 3.97856651 |
| 53 | ER overload response (GO:0006983) | 3.85847688 |
| 54 | response to pheromone (GO:0019236) | 3.80921988 |
| 55 | positive thymic T cell selection (GO:0045059) | 3.75961333 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.75611909 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75458891 |
| 58 | skeletal muscle tissue regeneration (GO:0043403) | 3.71999882 |
| 59 | negative regulation of organ growth (GO:0046621) | 3.69326893 |
| 60 | regulation of protein localization to cell surface (GO:2000008) | 3.67151856 |
| 61 | NADH metabolic process (GO:0006734) | 3.66641620 |
| 62 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.59749846 |
| 63 | protein-cofactor linkage (GO:0018065) | 3.49633037 |
| 64 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.47863581 |
| 65 | serotonin metabolic process (GO:0042428) | 3.45930074 |
| 66 | negative T cell selection (GO:0043383) | 3.45527437 |
| 67 | regulation of DNA endoreduplication (GO:0032875) | 3.43737911 |
| 68 | negative regulation of striated muscle tissue development (GO:0045843) | 3.42017778 |
| 69 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.38907259 |
| 70 | negative regulation of muscle tissue development (GO:1901862) | 3.36026580 |
| 71 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.34089690 |
| 72 | regulation of calcium ion import (GO:0090279) | 3.33306224 |
| 73 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.33206525 |
| 74 | positive regulation of striated muscle cell differentiation (GO:0051155) | 3.33093213 |
| 75 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.32239899 |
| 76 | adenosine metabolic process (GO:0046085) | 3.29740010 |
| 77 | myofibril assembly (GO:0030239) | 3.27071416 |
| 78 | activated T cell proliferation (GO:0050798) | 3.27063162 |
| 79 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.26786564 |
| 80 | response to inactivity (GO:0014854) | 3.25420544 |
| 81 | negative regulation of muscle organ development (GO:0048635) | 3.24800560 |
| 82 | positive regulation of myoblast differentiation (GO:0045663) | 3.21418785 |
| 83 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.20695817 |
| 84 | T-helper cell differentiation (GO:0042093) | 3.16848095 |
| 85 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.16848095 |
| 86 | T cell selection (GO:0045058) | 3.16629730 |
| 87 | pericardium development (GO:0060039) | 3.14137794 |
| 88 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.13359636 |
| 89 | negative regulation of B cell proliferation (GO:0030889) | 3.11408641 |
| 90 | cellular zinc ion homeostasis (GO:0006882) | 3.08394363 |
| 91 | negative regulation of striated muscle cell differentiation (GO:0051154) | 3.08017570 |
| 92 | vesicle transport along microtubule (GO:0047496) | 3.07741174 |
| 93 | positive regulation of extracellular matrix organization (GO:1903055) | 3.07713781 |
| 94 | positive regulation of cell junction assembly (GO:1901890) | 3.06559560 |
| 95 | positive regulation of focal adhesion assembly (GO:0051894) | 3.06559560 |
| 96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03661825 |
| 97 | regulation of microtubule polymerization (GO:0031113) | 3.03310511 |
| 98 | dopamine transport (GO:0015872) | 3.02194986 |
| 99 | interferon-gamma production (GO:0032609) | 3.02035753 |
| 100 | thymic T cell selection (GO:0045061) | 3.00123290 |
| 101 | nucleus localization (GO:0051647) | 2.97517192 |
| 102 | leukocyte aggregation (GO:0070486) | 2.95122998 |
| 103 | tachykinin receptor signaling pathway (GO:0007217) | 2.94080640 |
| 104 | response to interleukin-15 (GO:0070672) | 2.93338476 |
| 105 | detection of calcium ion (GO:0005513) | 2.93253669 |
| 106 | response to gravity (GO:0009629) | 2.92933418 |
| 107 | protein K63-linked deubiquitination (GO:0070536) | 2.92628982 |
| 108 | negative thymic T cell selection (GO:0045060) | 2.89337018 |
| 109 | skeletal muscle adaptation (GO:0043501) | 2.88692305 |
| 110 | response to insecticide (GO:0017085) | 2.88437547 |
| 111 | regulation of membrane depolarization (GO:0003254) | 2.88389668 |
| 112 | primary amino compound metabolic process (GO:1901160) | 2.86689819 |
| 113 | DNA deamination (GO:0045006) | 2.85860319 |
| 114 | behavioral response to nicotine (GO:0035095) | 2.85451161 |
| 115 | SMAD protein complex assembly (GO:0007183) | 2.84934876 |
| 116 | regulation of muscle adaptation (GO:0043502) | 2.84406479 |
| 117 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.83758014 |
| 118 | muscle cell fate commitment (GO:0042693) | 2.82553802 |
| 119 | T cell receptor signaling pathway (GO:0050852) | 2.80877940 |
| 120 | ethanol metabolic process (GO:0006067) | 2.80571238 |
| 121 | heart process (GO:0003015) | 2.80203934 |
| 122 | heart contraction (GO:0060047) | 2.80203934 |
| 123 | syncytium formation (GO:0006949) | 2.79358933 |
| 124 | autophagic vacuole fusion (GO:0000046) | 2.79102287 |
| 125 | negative regulation of T cell mediated immunity (GO:0002710) | 2.78699020 |
| 126 | positive regulation of skeletal muscle tissue development (GO:0048643) | 2.78390658 |
| 127 | myotube differentiation (GO:0014902) | 2.76233609 |
| 128 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.75439040 |
| 129 | viral protein processing (GO:0019082) | 2.74219980 |
| 130 | negative regulation of osteoblast proliferation (GO:0033689) | 2.72859900 |
| 131 | positive regulation of protein homodimerization activity (GO:0090073) | 2.71273410 |
| 132 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.70909866 |
| 133 | positive regulation of adherens junction organization (GO:1903393) | 2.69626030 |
| 134 | T cell differentiation involved in immune response (GO:0002292) | 2.67791269 |
| 135 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.67791269 |
| 136 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.67791269 |
| 137 | zinc ion homeostasis (GO:0055069) | 2.66714173 |
| 138 | response to xenobiotic stimulus (GO:0009410) | 2.63105979 |
| 139 | cellular copper ion homeostasis (GO:0006878) | 2.63044577 |
| 140 | Golgi transport vesicle coating (GO:0048200) | 2.62117364 |
| 141 | COPI coating of Golgi vesicle (GO:0048205) | 2.62117364 |
| 142 | trabecula formation (GO:0060343) | 2.62008275 |
| 143 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.61892230 |
| 144 | cardiac muscle cell development (GO:0055013) | 2.61791944 |
| 145 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.58821499 |
| 146 | membrane budding (GO:0006900) | 2.58106056 |
| 147 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.58071314 |
| 148 | regulation of oxidative phosphorylation (GO:0002082) | 2.57794459 |
| 149 | metallo-sulfur cluster assembly (GO:0031163) | 2.57163882 |
| 150 | iron-sulfur cluster assembly (GO:0016226) | 2.57163882 |
| 151 | positive regulation of mitochondrial fission (GO:0090141) | 2.56389704 |
| 152 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.56137019 |
| 153 | mitotic sister chromatid cohesion (GO:0007064) | 2.55612405 |
| 154 | lymphocyte costimulation (GO:0031294) | 2.54633573 |
| 155 | regulation of synaptic vesicle transport (GO:1902803) | 2.54436879 |
| 156 | catechol-containing compound biosynthetic process (GO:0009713) | 2.54129470 |
| 157 | catecholamine biosynthetic process (GO:0042423) | 2.54129470 |
| 158 | transcytosis (GO:0045056) | 2.52993849 |
| 159 | catecholamine transport (GO:0051937) | 2.52392219 |
| 160 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.52277470 |
| 161 | histone H2A ubiquitination (GO:0033522) | 2.50211066 |
| 162 | regulation of somitogenesis (GO:0014807) | 2.50154166 |
| 163 | T cell costimulation (GO:0031295) | 2.49644323 |
| 164 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.49608746 |
| 165 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.48684161 |
| 166 | stress granule assembly (GO:0034063) | 2.45908736 |
| 167 | positive regulation of B cell differentiation (GO:0045579) | 2.45190317 |
| 168 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.44930946 |
| 169 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43697048 |
| 170 | protein K48-linked deubiquitination (GO:0071108) | 2.43497180 |
| 171 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.41867573 |
| 172 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.41722157 |
| 173 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.41249260 |
| 174 | detection of bacterium (GO:0016045) | 2.40951993 |
| 175 | protein K11-linked ubiquitination (GO:0070979) | 2.37109041 |
| 176 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.36412879 |
| 177 | alpha-beta T cell differentiation (GO:0046632) | 2.36076858 |
| 178 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.35319844 |
| 179 | T cell activation involved in immune response (GO:0002286) | 2.33858320 |
| 180 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.33053282 |
| 181 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.31241624 |
| 182 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.31030374 |
| 183 | negative regulation of microtubule polymerization (GO:0031115) | 2.30672724 |
| 184 | organelle membrane fusion (GO:0090174) | 2.30366406 |
| 185 | regulation of translational termination (GO:0006449) | 2.28393898 |
| 186 | succinate metabolic process (GO:0006105) | 2.27542969 |
| 187 | positive regulation of DNA recombination (GO:0045911) | 2.25950278 |
| 188 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.25703993 |
| 189 | transferrin transport (GO:0033572) | 2.24103582 |
| 190 | regulation of isotype switching (GO:0045191) | 2.24031009 |
| 191 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.22452256 |
| 192 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.22042671 |
| 193 | norepinephrine metabolic process (GO:0042415) | 2.19787562 |
| 194 | regulation of defense response to virus by virus (GO:0050690) | 2.17721775 |
| 195 | detection of other organism (GO:0098543) | 2.16445670 |
| 196 | regulation of sarcomere organization (GO:0060297) | 12.9352448 |
| 197 | plasma membrane repair (GO:0001778) | 11.2901702 |
| 198 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 11.0983632 |
| 199 | regulation of skeletal muscle contraction (GO:0014819) | 10.3922228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 7.24565808 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.08203483 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.31639235 |
| 4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.31639235 |
| 5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.31639235 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.29578548 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.54598439 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.21005547 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.20973433 |
| 10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.95151075 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.77335277 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.58355181 |
| 13 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.36075240 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.18199167 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.15704048 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.15053276 |
| 17 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 2.12816917 |
| 18 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.09977328 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.08873341 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07456226 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00834640 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98336393 |
| 23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96725420 |
| 24 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.92552261 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.88626048 |
| 26 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87375229 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85761525 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.85015440 |
| 29 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.84044897 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.82008461 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80347585 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.76376772 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.75460123 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74493136 |
| 35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.69673740 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68318008 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65187523 |
| 38 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62679591 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62157566 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59618963 |
| 41 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55660113 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.55459843 |
| 43 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.54308984 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51783572 |
| 45 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51418306 |
| 46 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51318423 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50607244 |
| 48 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48451240 |
| 49 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47015538 |
| 50 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42186313 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40501924 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.39683491 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37193341 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34379012 |
| 55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32225074 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29563676 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27334072 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26256075 |
| 59 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26174856 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.25355585 |
| 61 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.25269154 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24193119 |
| 63 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.23651237 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.23582632 |
| 65 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23007980 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22216196 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21018118 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18546527 |
| 69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18007030 |
| 70 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.17980682 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16984016 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16596943 |
| 73 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16085540 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16066060 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15674207 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14258149 |
| 77 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.13773846 |
| 78 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13385223 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12448159 |
| 80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.12361274 |
| 81 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12288610 |
| 82 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11613260 |
| 83 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10686154 |
| 84 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10298886 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10046979 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09436589 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09362368 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05075190 |
| 89 | GATA3_26560356_Chip-Seq_TH1_Human | 1.04585488 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03866954 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03592633 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03100054 |
| 93 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.02616540 |
| 94 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02333959 |
| 95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01826057 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01817041 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01140087 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01038312 |
| 99 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.99918645 |
| 100 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99885875 |
| 101 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99878939 |
| 102 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99249596 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98583898 |
| 104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97849615 |
| 105 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.97242606 |
| 106 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.97117647 |
| 107 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97051305 |
| 108 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96544191 |
| 109 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96421184 |
| 110 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95727932 |
| 111 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95566050 |
| 112 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95336824 |
| 113 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94781858 |
| 114 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94767288 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94231851 |
| 116 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93585617 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93570511 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93526092 |
| 119 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93210948 |
| 120 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.93106851 |
| 121 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.93053318 |
| 122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92744757 |
| 123 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.92631263 |
| 124 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92127550 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91618910 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91515188 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91367143 |
| 128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91083544 |
| 129 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.90620306 |
| 130 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90327993 |
| 131 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89657646 |
| 132 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88850851 |
| 133 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88846067 |
| 134 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88545205 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87960567 |
| 136 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87111097 |
| 137 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86821355 |
| 138 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86727024 |
| 139 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.86472870 |
| 140 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85621859 |
| 141 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.85558600 |
| 142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85222485 |
| 143 | P300_19829295_ChIP-Seq_ESCs_Human | 0.85215978 |
| 144 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.85192695 |
| 145 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85113962 |
| 146 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83859598 |
| 147 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83722569 |
| 148 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82906983 |
| 149 | NCOR_22424771_ChIP-Seq_293T_Human | 0.82784047 |
| 150 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78983285 |
| 151 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.78856743 |
| 152 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78689365 |
| 153 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.76717400 |
| 154 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.76597380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 5.85526240 |
| 2 | MP0002102_abnormal_ear_morphology | 5.55448311 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 4.29839764 |
| 4 | MP0000751_myopathy | 4.26956749 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.58972609 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.58630944 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.33699372 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.91536436 |
| 9 | MP0005671_abnormal_response_to | 2.53374033 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.47004095 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.23162083 |
| 12 | MP0008789_abnormal_olfactory_epithelium | 2.20138860 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.16535195 |
| 14 | MP0001529_abnormal_vocalization | 2.15099152 |
| 15 | MP0003724_increased_susceptibility_to | 2.10932877 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.05357315 |
| 17 | MP0005330_cardiomyopathy | 2.00133501 |
| 18 | MP0003950_abnormal_plasma_membrane | 12.2408466 |
| 19 | MP0004036_abnormal_muscle_relaxation | 1.90943346 |
| 20 | MP0004147_increased_porphyrin_level | 1.90722590 |
| 21 | MP0003303_peritoneal_inflammation | 1.84046630 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.82759323 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.79597282 |
| 24 | MP0005083_abnormal_biliary_tract | 1.78735014 |
| 25 | MP0002269_muscular_atrophy | 1.76575113 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.71515298 |
| 27 | MP0009697_abnormal_copulation | 1.69937467 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.59354372 |
| 29 | MP0001984_abnormal_olfaction | 1.56176606 |
| 30 | MP0005499_abnormal_olfactory_system | 1.55016776 |
| 31 | MP0005394_taste/olfaction_phenotype | 1.55016776 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.50224844 |
| 33 | MP0003787_abnormal_imprinting | 1.50058893 |
| 34 | MP0004883_abnormal_blood_vessel | 1.49862393 |
| 35 | MP0008057_abnormal_DNA_replication | 1.48425447 |
| 36 | MP0003252_abnormal_bile_duct | 1.46583172 |
| 37 | MP0005387_immune_system_phenotype | 1.46127714 |
| 38 | MP0001790_abnormal_immune_system | 1.46127714 |
| 39 | MP0002132_abnormal_respiratory_system | 1.46087872 |
| 40 | MP0008260_abnormal_autophagy | 1.45752018 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.43847757 |
| 42 | MP0001542_abnormal_bone_strength | 1.43800271 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.43754980 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.40848065 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.39379456 |
| 46 | MP0005187_abnormal_penis_morphology | 1.39094264 |
| 47 | MP0002398_abnormal_bone_marrow | 1.38824635 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.35281450 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.34693274 |
| 50 | MP0001800_abnormal_humoral_immune | 1.34526398 |
| 51 | MP0008872_abnormal_physiological_respon | 1.31010888 |
| 52 | MP0001293_anophthalmia | 1.30448558 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.30390560 |
| 54 | MP0003786_premature_aging | 1.28744628 |
| 55 | MP0003868_abnormal_feces_composition | 1.26148644 |
| 56 | MP0005310_abnormal_salivary_gland | 1.25789395 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.25338218 |
| 58 | MP0001853_heart_inflammation | 1.24961823 |
| 59 | MP0000685_abnormal_immune_system | 1.24273426 |
| 60 | MP0004272_abnormal_basement_membrane | 1.24059205 |
| 61 | MP0001764_abnormal_homeostasis | 1.23729192 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.23606495 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.23112245 |
| 64 | MP0002638_abnormal_pupillary_reflex | 1.22152317 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.21904604 |
| 66 | MP0001819_abnormal_immune_cell | 1.19437040 |
| 67 | MP0005365_abnormal_bile_salt | 1.19208439 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.18266731 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.18248789 |
| 70 | MP0002006_tumorigenesis | 1.17538227 |
| 71 | MP0006292_abnormal_olfactory_placode | 1.17466693 |
| 72 | MP0005620_abnormal_muscle_contractility | 1.16131716 |
| 73 | MP0001873_stomach_inflammation | 1.15304184 |
| 74 | MP0002405_respiratory_system_inflammati | 1.14894602 |
| 75 | MP0004087_abnormal_muscle_fiber | 1.14519398 |
| 76 | MP0005360_urolithiasis | 1.13744474 |
| 77 | MP0003122_maternal_imprinting | 1.12330168 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.12309095 |
| 79 | MP0002139_abnormal_hepatobiliary_system | 1.11672936 |
| 80 | MP0002693_abnormal_pancreas_physiology | 1.10157123 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.10012532 |
| 82 | MP0004924_abnormal_behavior | 1.10012532 |
| 83 | MP0005369_muscle_phenotype | 1.09554195 |
| 84 | MP0004270_analgesia | 1.08478211 |
| 85 | MP0008775_abnormal_heart_ventricle | 1.08280224 |
| 86 | MP0000716_abnormal_immune_system | 1.07990747 |
| 87 | MP0008058_abnormal_DNA_repair | 1.07093057 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.06866264 |
| 89 | MP0002723_abnormal_immune_serum | 1.06420846 |
| 90 | MP0005408_hypopigmentation | 1.06118190 |
| 91 | MP0010368_abnormal_lymphatic_system | 1.05429576 |
| 92 | MP0000013_abnormal_adipose_tissue | 1.04858249 |
| 93 | MP0002064_seizures | 1.04633133 |
| 94 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04205620 |
| 95 | MP0002722_abnormal_immune_system | 1.04092373 |
| 96 | MP0000467_abnormal_esophagus_morphology | 1.03588156 |
| 97 | MP0004215_abnormal_myocardial_fiber | 1.03206718 |
| 98 | MP0002166_altered_tumor_susceptibility | 1.01390816 |
| 99 | MP0003111_abnormal_nucleus_morphology | 1.00192514 |
| 100 | MP0003866_abnormal_defecation | 0.99492987 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.98539597 |
| 102 | MP0005220_abnormal_exocrine_pancreas | 0.97910369 |
| 103 | MP0005084_abnormal_gallbladder_morpholo | 0.95310054 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.94745013 |
| 105 | MP0002452_abnormal_antigen_presenting | 0.93532879 |
| 106 | MP0002429_abnormal_blood_cell | 0.91904933 |
| 107 | MP0001440_abnormal_grooming_behavior | 0.91156575 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.91014915 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.90986559 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.90879642 |
| 111 | MP0004130_abnormal_muscle_cell | 0.90057289 |
| 112 | MP0000372_irregular_coat_pigmentation | 0.89030720 |
| 113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88795921 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.88791562 |
| 115 | MP0003121_genomic_imprinting | 0.88535996 |
| 116 | MP0003646_muscle_fatigue | 0.88100272 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 0.88070813 |
| 118 | MP0000604_amyloidosis | 0.87985691 |
| 119 | MP0003635_abnormal_synaptic_transmissio | 0.87745783 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.86848936 |
| 121 | MP0005385_cardiovascular_system_phenoty | 0.86302691 |
| 122 | MP0001544_abnormal_cardiovascular_syste | 0.86302691 |
| 123 | MP0003879_abnormal_hair_cell | 0.86136803 |
| 124 | MP0004484_altered_response_of | 0.85718883 |
| 125 | MP0003186_abnormal_redox_activity | 0.85667354 |
| 126 | MP0010386_abnormal_urinary_bladder | 0.85616673 |
| 127 | MP0009745_abnormal_behavioral_response | 0.84347758 |
| 128 | MP0002736_abnormal_nociception_after | 0.84046583 |
| 129 | MP0002009_preneoplasia | 0.82386259 |
| 130 | MP0009785_altered_susceptibility_to | 0.81895852 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.81881798 |
| 132 | MP0005000_abnormal_immune_tolerance | 0.81636858 |
| 133 | MP0002876_abnormal_thyroid_physiology | 0.81490897 |
| 134 | MP0009046_muscle_twitch | 0.80422844 |
| 135 | MP0002163_abnormal_gland_morphology | 0.80389351 |
| 136 | MP0001835_abnormal_antigen_presentation | 0.79796494 |
| 137 | MP0002063_abnormal_learning/memory/cond | 0.78116427 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.77500494 |
| 139 | MP0004859_abnormal_synaptic_plasticity | 0.76898719 |
| 140 | MP0005171_absent_coat_pigmentation | 0.76522923 |
| 141 | MP0001944_abnormal_pancreas_morphology | 0.76360373 |
| 142 | MP0003195_calcinosis | 0.75893105 |
| 143 | MP0001756_abnormal_urination | 0.75366565 |
| 144 | MP0004957_abnormal_blastocyst_morpholog | 0.74936223 |
| 145 | MP0002928_abnormal_bile_duct | 0.74138838 |
| 146 | MP0003436_decreased_susceptibility_to | 0.73828818 |
| 147 | MP0002822_catalepsy | 0.72640453 |
| 148 | MP0002127_abnormal_cardiovascular_syste | 0.72140355 |
| 149 | MP0003828_pulmonary_edema | 0.71850989 |
| 150 | MP0001177_atelectasis | 0.71415175 |
| 151 | MP0003077_abnormal_cell_cycle | 0.71286681 |
| 152 | MP0002095_abnormal_skin_pigmentation | 0.70444605 |
| 153 | MP0005319_abnormal_enzyme/_coenzyme | 0.67691777 |
| 154 | MP0000733_abnormal_muscle_development | 0.67321071 |
| 155 | MP0005166_decreased_susceptibility_to | 0.65551943 |
| 156 | MP0000678_abnormal_parathyroid_gland | 0.65053059 |
| 157 | MP0010094_abnormal_chromosome_stability | 0.64483620 |
| 158 | MP0005164_abnormal_response_to | 0.64258621 |
| 159 | MP0003045_fibrosis | 0.61964685 |
| 160 | MP0001270_distended_abdomen | 0.60899611 |
| 161 | MP0000427_abnormal_hair_cycle | 0.60661884 |
| 162 | MP0002933_joint_inflammation | 0.60495542 |
| 163 | MP0008995_early_reproductive_senescence | 0.60427704 |
| 164 | MP0000647_abnormal_sebaceous_gland | 0.56199149 |
| 165 | MP0003453_abnormal_keratinocyte_physiol | 0.54787259 |
| 166 | MP0002108_abnormal_muscle_morphology | 0.54488273 |
| 167 | MP0002234_abnormal_pharynx_morphology | 0.51809897 |
| 168 | MP0002160_abnormal_reproductive_system | 0.47652010 |
| 169 | MP0002148_abnormal_hypersensitivity_rea | 0.47353098 |
| 170 | MP0003191_abnormal_cellular_cholesterol | 0.47165650 |
| 171 | MP0005023_abnormal_wound_healing | 0.43949770 |
| 172 | MP0002089_abnormal_postnatal_growth/wei | 0.43446781 |
| 173 | MP0005389_reproductive_system_phenotype | 0.42838998 |
| 174 | MP0002896_abnormal_bone_mineralization | 0.40346652 |
| 175 | MP0005376_homeostasis/metabolism_phenot | 0.38520668 |
| 176 | MP0000681_abnormal_thyroid_gland | 0.38132240 |
| 177 | MP0001664_abnormal_digestion | 0.37931583 |
| 178 | MP0003718_maternal_effect | 0.36451922 |
| 179 | MP0001919_abnormal_reproductive_system | 0.35100614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle hypertrophy of the lower extremities (HP:0008968) | 9.74634806 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 9.37438809 |
| 3 | Abnormality of the left ventricular outflow tract (HP:0011103) | 9.22956058 |
| 4 | Subaortic stenosis (HP:0001682) | 9.22956058 |
| 5 | Exercise-induced myalgia (HP:0003738) | 9.05829788 |
| 6 | Asymmetric septal hypertrophy (HP:0001670) | 7.12246246 |
| 7 | Renal cortical cysts (HP:0000803) | 6.19849266 |
| 8 | Muscle stiffness (HP:0003552) | 5.81916518 |
| 9 | Sudden death (HP:0001699) | 5.78932874 |
| 10 | Myotonia (HP:0002486) | 5.70542479 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.76874433 |
| 12 | Arterial tortuosity (HP:0005116) | 4.49391975 |
| 13 | Increased serum pyruvate (HP:0003542) | 4.13248110 |
| 14 | Prolonged QT interval (HP:0001657) | 4.12663501 |
| 15 | Abnormal hair whorl (HP:0010721) | 4.03094675 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 4.00011312 |
| 17 | Neck muscle weakness (HP:0000467) | 3.99053188 |
| 18 | Hypothermia (HP:0002045) | 3.95649615 |
| 19 | Vascular tortuosity (HP:0004948) | 3.90954318 |
| 20 | Gowers sign (HP:0003391) | 3.63344551 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.56642600 |
| 22 | Hyperactive renin-angiotensin system (HP:0000841) | 3.51938681 |
| 23 | Abnormality of the renal cortex (HP:0011035) | 3.51702026 |
| 24 | Decreased circulating renin level (HP:0003351) | 3.50796968 |
| 25 | Chronic bronchitis (HP:0004469) | 3.46339196 |
| 26 | Abnormality of glycolysis (HP:0004366) | 3.42653075 |
| 27 | Brushfield spots (HP:0001088) | 3.28312739 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.26998794 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.22345806 |
| 30 | Atonic seizures (HP:0010819) | 3.21223938 |
| 31 | Turricephaly (HP:0000262) | 3.21132979 |
| 32 | Hyponatremia (HP:0002902) | 3.18094111 |
| 33 | Palpebral edema (HP:0100540) | 3.16665661 |
| 34 | Type 2 muscle fiber atrophy (HP:0003554) | 3.13701501 |
| 35 | Poikilocytosis (HP:0004447) | 3.09628804 |
| 36 | Hypokalemic alkalosis (HP:0001949) | 3.04873372 |
| 37 | Rimmed vacuoles (HP:0003805) | 3.03767754 |
| 38 | Limb hypertonia (HP:0002509) | 3.01776954 |
| 39 | Failure to thrive in infancy (HP:0001531) | 3.01106977 |
| 40 | Spontaneous hematomas (HP:0007420) | 3.01062365 |
| 41 | Abnormal cartilage morphology (HP:0002763) | 2.96757857 |
| 42 | Visual hallucinations (HP:0002367) | 2.96360378 |
| 43 | Spondylolisthesis (HP:0003302) | 2.89990490 |
| 44 | T lymphocytopenia (HP:0005403) | 2.78916844 |
| 45 | Abnormal gallbladder morphology (HP:0012437) | 2.78261468 |
| 46 | Volvulus (HP:0002580) | 2.78175689 |
| 47 | Ventricular arrhythmia (HP:0004308) | 2.77098164 |
| 48 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.76430519 |
| 49 | Cholelithiasis (HP:0001081) | 2.73861788 |
| 50 | Thyroid-stimulating hormone excess (HP:0002925) | 2.71167559 |
| 51 | Absence seizures (HP:0002121) | 2.69728506 |
| 52 | Shoulder girdle muscle weakness (HP:0003547) | 2.67559446 |
| 53 | Hyperkalemia (HP:0002153) | 2.63963842 |
| 54 | Muscle fiber atrophy (HP:0100295) | 2.63719240 |
| 55 | Hyperaldosteronism (HP:0000859) | 2.62870590 |
| 56 | Skin nodule (HP:0200036) | 2.60932181 |
| 57 | Hyperglycemia (HP:0003074) | 2.60407761 |
| 58 | Hyporeflexia of lower limbs (HP:0002600) | 2.60340911 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.60044893 |
| 60 | Aortic aneurysm (HP:0004942) | 2.59979250 |
| 61 | Focal motor seizures (HP:0011153) | 2.59528143 |
| 62 | Hypoplasia of the thymus (HP:0000778) | 2.59126226 |
| 63 | Dialeptic seizures (HP:0011146) | 2.59077563 |
| 64 | Osteomalacia (HP:0002749) | 2.48189331 |
| 65 | Clitoromegaly (HP:0000057) | 2.47178228 |
| 66 | Acanthocytosis (HP:0001927) | 2.46169457 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.34541233 |
| 68 | Limb dystonia (HP:0002451) | 2.31509520 |
| 69 | Abnormality of placental membranes (HP:0011409) | 2.26897971 |
| 70 | Amniotic constriction ring (HP:0009775) | 2.26897971 |
| 71 | Abnormality of alanine metabolism (HP:0010916) | 2.26298003 |
| 72 | Hyperalaninemia (HP:0003348) | 2.26298003 |
| 73 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26298003 |
| 74 | Increased serum ferritin (HP:0003281) | 2.25338811 |
| 75 | Febrile seizures (HP:0002373) | 2.24496426 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.21812575 |
| 77 | Hyperbilirubinemia (HP:0002904) | 2.20689301 |
| 78 | Increased corneal curvature (HP:0100692) | 2.20427990 |
| 79 | Keratoconus (HP:0000563) | 2.20427990 |
| 80 | Abnormality of sodium homeostasis (HP:0010931) | 2.20173262 |
| 81 | Hypochromic anemia (HP:0001931) | 2.18663373 |
| 82 | Microcytic anemia (HP:0001935) | 2.17468719 |
| 83 | IgG deficiency (HP:0004315) | 2.17018533 |
| 84 | Abnormal EKG (HP:0003115) | 2.16103417 |
| 85 | Abnormal biliary tract morphology (HP:0012440) | 2.15682390 |
| 86 | Pelvic girdle muscle weakness (HP:0003749) | 2.15542117 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.15028080 |
| 88 | Posterior subcapsular cataract (HP:0007787) | 2.13492052 |
| 89 | Hypokalemia (HP:0002900) | 2.11944481 |
| 90 | Abnormality of the thymus (HP:0000777) | 2.11422011 |
| 91 | Reticulocytosis (HP:0001923) | 2.09271368 |
| 92 | Metatarsus adductus (HP:0001840) | 2.07807251 |
| 93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06733272 |
| 94 | Papilledema (HP:0001085) | 2.06695274 |
| 95 | Death in childhood (HP:0003819) | 2.05938981 |
| 96 | Drooling (HP:0002307) | 2.05494963 |
| 97 | Excessive salivation (HP:0003781) | 2.05494963 |
| 98 | Bronchitis (HP:0012387) | 2.05285763 |
| 99 | Popliteal pterygium (HP:0009756) | 2.05143128 |
| 100 | Aortic regurgitation (HP:0001659) | 2.03856436 |
| 101 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02520114 |
| 102 | Hypoglycemic seizures (HP:0002173) | 2.01591983 |
| 103 | Focal seizures (HP:0007359) | 2.00462203 |
| 104 | Calf muscle hypertrophy (HP:0008981) | 10.9014380 |
| 105 | Recurrent abscess formation (HP:0002722) | 1.98258030 |
| 106 | Fatigable weakness (HP:0003473) | 1.97747299 |
| 107 | Abnormality of the neuromuscular junction (HP:0003398) | 1.97747299 |
| 108 | Fair hair (HP:0002286) | 1.94018331 |
| 109 | Abnormality of the labia minora (HP:0012880) | 1.94001641 |
| 110 | Hepatocellular necrosis (HP:0001404) | 1.92523542 |
| 111 | Severe combined immunodeficiency (HP:0004430) | 1.90791235 |
| 112 | Areflexia of lower limbs (HP:0002522) | 1.90023097 |
| 113 | Hyperthyroidism (HP:0000836) | 1.90020201 |
| 114 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.89967957 |
| 115 | Pili torti (HP:0003777) | 1.89591903 |
| 116 | Pustule (HP:0200039) | 1.89566387 |
| 117 | Aortic dissection (HP:0002647) | 1.89067422 |
| 118 | Oligomenorrhea (HP:0000876) | 1.89000530 |
| 119 | Abnormal pupillary function (HP:0007686) | 1.88437278 |
| 120 | Submucous cleft hard palate (HP:0000176) | 1.88000505 |
| 121 | IgM deficiency (HP:0002850) | 1.85476257 |
| 122 | Epileptiform EEG discharges (HP:0011182) | 1.84008521 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83981527 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83153277 |
| 125 | Gout (HP:0001997) | 1.81865896 |
| 126 | Combined immunodeficiency (HP:0005387) | 1.81837805 |
| 127 | B lymphocytopenia (HP:0010976) | 1.81640683 |
| 128 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.81501984 |
| 129 | Exotropia (HP:0000577) | 1.81387068 |
| 130 | Hypotension (HP:0002615) | 1.81036851 |
| 131 | Cubitus valgus (HP:0002967) | 1.80611925 |
| 132 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.80212249 |
| 133 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.80212249 |
| 134 | Progressive inability to walk (HP:0002505) | 1.79989325 |
| 135 | Chronic diarrhea (HP:0002028) | 1.79598298 |
| 136 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79187615 |
| 137 | Hepatic necrosis (HP:0002605) | 1.78498277 |
| 138 | Menstrual irregularities (HP:0000858) | 1.77483865 |
| 139 | Constricted visual fields (HP:0001133) | 1.76787686 |
| 140 | Dry hair (HP:0011359) | 1.76531899 |
| 141 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76395336 |
| 142 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76395336 |
| 143 | Thyroiditis (HP:0100646) | 1.76040934 |
| 144 | Ridged nail (HP:0001807) | 1.75518932 |
| 145 | Abnormal gallbladder physiology (HP:0012438) | 1.75427058 |
| 146 | Cholecystitis (HP:0001082) | 1.75427058 |
| 147 | Poor suck (HP:0002033) | 1.75310028 |
| 148 | Curly hair (HP:0002212) | 1.74555859 |
| 149 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73192185 |
| 150 | Weak cry (HP:0001612) | 1.71408658 |
| 151 | Entropion (HP:0000621) | 1.70336180 |
| 152 | Lower limb muscle weakness (HP:0007340) | 1.69797749 |
| 153 | Hypsarrhythmia (HP:0002521) | 1.69426504 |
| 154 | Dysautonomia (HP:0002459) | 1.68743041 |
| 155 | Overlapping toe (HP:0001845) | 1.68462247 |
| 156 | Generalized tonic-clonic seizures (HP:0002069) | 1.67982957 |
| 157 | Oral leukoplakia (HP:0002745) | 1.67614748 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.67388916 |
| 159 | Panhypogammaglobulinemia (HP:0003139) | 1.66789419 |
| 160 | Nemaline bodies (HP:0003798) | 1.66437726 |
| 161 | Cellular immunodeficiency (HP:0005374) | 1.65526390 |
| 162 | Delusions (HP:0000746) | 1.64436918 |
| 163 | Renal salt wasting (HP:0000127) | 1.64115184 |
| 164 | Protrusio acetabuli (HP:0003179) | 1.63533737 |
| 165 | Left ventricular hypertrophy (HP:0001712) | 1.63291382 |
| 166 | Hip dysplasia (HP:0001385) | 1.61107834 |
| 167 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.60650355 |
| 168 | Abnormality of the clitoris (HP:0000056) | 1.59449371 |
| 169 | Abnormality of B cell number (HP:0010975) | 1.55198933 |
| 170 | Tubulointerstitial nephritis (HP:0001970) | 1.54968695 |
| 171 | Abnormality of the intervertebral disk (HP:0005108) | 1.53777719 |
| 172 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.50787033 |
| 173 | Hamartoma of the eye (HP:0010568) | 1.47714882 |
| 174 | Childhood onset (HP:0011463) | 1.47221108 |
| 175 | Aplastic anemia (HP:0001915) | 1.44723129 |
| 176 | Rhabdomyolysis (HP:0003201) | 1.44582542 |
| 177 | Meningioma (HP:0002858) | 1.42893316 |
| 178 | Difficulty walking (HP:0002355) | 1.42583375 |
| 179 | Striae distensae (HP:0001065) | 1.42305213 |
| 180 | Prostate neoplasm (HP:0100787) | 1.42070125 |
| 181 | Palpitations (HP:0001962) | 1.40254903 |
| 182 | Mitochondrial inheritance (HP:0001427) | 1.39394483 |
| 183 | Tinnitus (HP:0000360) | 1.38355151 |
| 184 | Acute necrotizing encephalopathy (HP:0006965) | 1.34724980 |
| 185 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.34531334 |
| 186 | Anhidrosis (HP:0000970) | 1.33754590 |
| 187 | Periorbital edema (HP:0100539) | 1.30134504 |
| 188 | Increased CSF lactate (HP:0002490) | 1.29929829 |
| 189 | Inability to walk (HP:0002540) | 1.27462366 |
| 190 | Nonprogressive disorder (HP:0003680) | 1.26391507 |
| 191 | Progressive macrocephaly (HP:0004481) | 1.24570394 |
| 192 | Facial edema (HP:0000282) | 1.23444761 |
| 193 | Muscle fiber inclusion bodies (HP:0100299) | 1.23360152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK5 | 7.17921668 |
| 2 | CDK8 | 5.77305267 |
| 3 | MUSK | 5.37562007 |
| 4 | SCYL2 | 3.78197508 |
| 5 | TSSK6 | 3.67153192 |
| 6 | MAP4K1 | 3.28637642 |
| 7 | WNK3 | 3.22772842 |
| 8 | TXK | 3.21119933 |
| 9 | MAP3K12 | 3.19554570 |
| 10 | PIK3CG | 3.09160355 |
| 11 | EIF2AK3 | 2.85797274 |
| 12 | TLK1 | 2.85368973 |
| 13 | TAOK3 | 2.70892081 |
| 14 | LMTK2 | 2.43132807 |
| 15 | INSRR | 2.40160447 |
| 16 | DMPK | 2.38363478 |
| 17 | CDK9 | 2.32887730 |
| 18 | FRK | 2.19559212 |
| 19 | EIF2AK1 | 2.17978730 |
| 20 | STK16 | 2.07750395 |
| 21 | CCNB1 | 2.02207655 |
| 22 | ITK | 1.95671922 |
| 23 | TYK2 | 1.84562638 |
| 24 | SRPK1 | 1.80928414 |
| 25 | MAP3K7 | 1.79890183 |
| 26 | MOS | 1.78568346 |
| 27 | ZAP70 | 1.63014420 |
| 28 | MAP3K13 | 1.62589716 |
| 29 | GRK6 | 1.61864131 |
| 30 | TEC | 1.57442703 |
| 31 | CDK4 | 1.50273566 |
| 32 | PAK6 | 1.46928663 |
| 33 | SGK2 | 1.40547158 |
| 34 | IRAK4 | 1.38555923 |
| 35 | NLK | 1.37958764 |
| 36 | PIK3CA | 1.32159837 |
| 37 | PLK2 | 1.25292476 |
| 38 | ZAK | 1.24905820 |
| 39 | PLK3 | 1.21201188 |
| 40 | GRK5 | 1.18379029 |
| 41 | NUAK1 | 1.17603482 |
| 42 | SGK3 | 1.17190235 |
| 43 | JAK2 | 1.16824721 |
| 44 | KSR2 | 1.15270109 |
| 45 | VRK1 | 1.13221395 |
| 46 | MST4 | 1.07826567 |
| 47 | MAPK11 | 1.04979932 |
| 48 | BMPR1B | 1.01414685 |
| 49 | VRK2 | 0.99092996 |
| 50 | KSR1 | 0.98727967 |
| 51 | JAK3 | 0.97061387 |
| 52 | STK24 | 0.93979545 |
| 53 | MAP2K7 | 0.93546113 |
| 54 | MAPK13 | 0.92361703 |
| 55 | CSNK1G3 | 0.92239767 |
| 56 | TRIM28 | 0.89805946 |
| 57 | PRKCH | 0.88280186 |
| 58 | FGFR4 | 0.86010426 |
| 59 | DYRK3 | 0.85855865 |
| 60 | OBSCN | 0.84943683 |
| 61 | STK10 | 0.83943876 |
| 62 | MAPK7 | 0.83831303 |
| 63 | FGFR2 | 0.83778337 |
| 64 | PRKACB | 0.83754837 |
| 65 | PBK | 0.82480148 |
| 66 | EEF2K | 0.81323653 |
| 67 | SYK | 0.81076549 |
| 68 | CSNK1D | 0.80389874 |
| 69 | CSNK1G2 | 0.79723400 |
| 70 | GRK7 | 0.79701672 |
| 71 | JAK1 | 0.78617562 |
| 72 | AKT3 | 0.77045978 |
| 73 | SGK223 | 0.76922968 |
| 74 | SGK494 | 0.76922968 |
| 75 | FLT3 | 0.76173267 |
| 76 | MAP3K1 | 0.75461161 |
| 77 | PRKCQ | 0.75419116 |
| 78 | RAF1 | 0.75360596 |
| 79 | MAP3K4 | 0.73429010 |
| 80 | CASK | 0.73323787 |
| 81 | RPS6KB1 | 0.72748109 |
| 82 | CLK1 | 0.71942763 |
| 83 | SIK2 | 0.70816894 |
| 84 | DAPK2 | 0.68909001 |
| 85 | MAP4K2 | 0.66457406 |
| 86 | GRK1 | 0.63889527 |
| 87 | CAMK2D | 0.63014702 |
| 88 | CAMKK2 | 0.61833992 |
| 89 | IKBKB | 0.56274269 |
| 90 | PAK2 | 0.56192729 |
| 91 | CDK3 | 0.56176978 |
| 92 | PKN1 | 0.55843823 |
| 93 | BUB1 | 0.55719314 |
| 94 | RET | 0.54637295 |
| 95 | HIPK2 | 0.54512970 |
| 96 | DAPK1 | 0.54320651 |
| 97 | TAF1 | 0.53890358 |
| 98 | SIK3 | 0.52404429 |
| 99 | MYLK | 0.51990768 |
| 100 | PASK | 0.51718635 |
| 101 | BRSK2 | 0.51153807 |
| 102 | ABL1 | 0.50818328 |
| 103 | PDK1 | 0.50190524 |
| 104 | ERBB4 | 0.49060302 |
| 105 | FGFR3 | 0.47902641 |
| 106 | FGFR1 | 0.47740402 |
| 107 | STK4 | 0.47196146 |
| 108 | LCK | 0.47154084 |
| 109 | MELK | 0.47018198 |
| 110 | PTK2B | 0.46627009 |
| 111 | PRKAA1 | 0.46598400 |
| 112 | DYRK1A | 0.45952043 |
| 113 | CDK6 | 0.45106845 |
| 114 | CSNK1A1L | 0.45056539 |
| 115 | DYRK1B | 0.44810722 |
| 116 | IRAK2 | 0.43960579 |
| 117 | IKBKE | 0.43166185 |
| 118 | CSNK1G1 | 0.42890690 |
| 119 | AURKA | 0.41519465 |
| 120 | STK3 | 0.41339187 |
| 121 | FGR | 0.40861788 |
| 122 | PIM2 | 0.40291394 |
| 123 | NTRK3 | 0.40068176 |
| 124 | FES | 0.39234238 |
| 125 | PIM1 | 0.39198414 |
| 126 | TBK1 | 0.38108244 |
| 127 | MAPKAPK3 | 0.37203790 |
| 128 | NEK6 | 0.37156691 |
| 129 | BCR | 0.37153445 |
| 130 | ADRBK2 | 0.35794451 |
| 131 | MAPK12 | 0.35454820 |
| 132 | TNK2 | 0.35365188 |
| 133 | CSNK2A2 | 0.35364271 |
| 134 | BRSK1 | 0.34679725 |
| 135 | PINK1 | 0.34646194 |
| 136 | EIF2AK2 | 0.33562450 |
| 137 | STK38L | 0.33515783 |
| 138 | CAMK2G | 0.33230662 |
| 139 | IGF1R | 0.32551170 |
| 140 | EGFR | 0.32535376 |
| 141 | NME1 | 0.32529241 |
| 142 | BRAF | 0.32228550 |
| 143 | CDC7 | 0.31024938 |
| 144 | MAPK4 | 0.30664366 |
| 145 | FER | 0.29869056 |
| 146 | MAP3K11 | 0.29632992 |
| 147 | RIPK4 | 0.29528172 |
| 148 | LYN | 0.29447808 |
| 149 | PRKCE | 0.29226733 |
| 150 | AURKB | 0.28442710 |
| 151 | NTRK2 | 0.28211002 |
| 152 | TGFBR2 | 0.27607836 |
| 153 | CSNK2A1 | 0.27311074 |
| 154 | HCK | 0.24805294 |
| 155 | ERBB3 | 0.24691857 |
| 156 | NEK1 | 0.23452289 |
| 157 | MARK2 | 0.22606545 |
| 158 | PRKCG | 0.22341172 |
| 159 | RPS6KA5 | 0.22150101 |
| 160 | CAMK2A | 0.20130975 |
| 161 | CAMK2B | 0.19118826 |
| 162 | CSF1R | 0.18894757 |
| 163 | MAP3K10 | 0.18587008 |
| 164 | RPS6KA4 | 0.17681821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pyruvate metabolism_Homo sapiens_hsa00620 | 3.23832701 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.05508107 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.92123098 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.87366060 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.72838600 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.70243222 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.69696013 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.66927741 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.54120098 |
| 10 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.53198109 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.37548434 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.36960968 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.33035265 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21014707 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 2.18633687 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 2.10452883 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.10436859 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08949579 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.07892888 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06829216 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.04512166 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01529418 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98832770 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.81657785 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.81615222 |
| 26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.79159045 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.78617395 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.78519963 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.70737025 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70199033 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.65901537 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.65543784 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58788589 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.56990871 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.54929408 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51192423 |
| 37 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.49020330 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.48043237 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45197780 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.40531748 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35425302 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.32991409 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31038496 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29050396 |
| 45 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.28241510 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27910981 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27418067 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.25741189 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22534696 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21504166 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21127498 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 1.21020975 |
| 53 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19364991 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18839514 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.18561584 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.17960269 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 1.15654193 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 1.14487237 |
| 59 | Measles_Homo sapiens_hsa05162 | 1.14400498 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14234033 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10950911 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10259126 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.10070263 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09751254 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08216811 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 1.08111803 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 1.07123167 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07039293 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 1.06067599 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03563344 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03004673 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 1.01754018 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01171526 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00982356 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00670202 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.99121621 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.96710365 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94679383 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92273987 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91970769 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91619096 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.91267601 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91085156 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91054036 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90314384 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.90125924 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89891131 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89664276 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89331676 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88500040 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86440640 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85636828 |
| 93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84974825 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84002932 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83343185 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82557214 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81062069 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80941540 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80450567 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78977725 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77065184 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76899299 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76242595 |
| 104 | RNA transport_Homo sapiens_hsa03013 | 0.75474235 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.75301836 |
| 106 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74299044 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73766179 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72510166 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72206224 |
| 110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70268763 |
| 111 | Ribosome_Homo sapiens_hsa03010 | 0.69696553 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69655679 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69093356 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.68741181 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.66892806 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65978082 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65040884 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64353867 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.63834914 |
| 120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62853658 |
| 121 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62269005 |
| 122 | * Spliceosome_Homo sapiens_hsa03040 | 0.61875747 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60964880 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.60452752 |
| 125 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58948364 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57273923 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57166029 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55202984 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54482117 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53787291 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53525544 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53428313 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52471254 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.52373825 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.52136906 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51649413 |
| 137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51078087 |
| 138 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50802438 |
| 139 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50682517 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.49831109 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49209441 |
| 142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49005538 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48066889 |
| 144 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47895077 |
| 145 | Purine metabolism_Homo sapiens_hsa00230 | 0.47781508 |
| 146 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47223469 |
| 147 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46919243 |
| 148 | Renin secretion_Homo sapiens_hsa04924 | 0.46193285 |
| 149 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45891567 |
| 150 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45134829 |
| 151 | DNA replication_Homo sapiens_hsa03030 | 0.44743420 |
| 152 | Endocytosis_Homo sapiens_hsa04144 | 0.44584990 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44243553 |
| 154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43106080 |
| 155 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42765800 |
| 156 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39704969 |
| 157 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39372242 |
| 158 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38180320 |
| 159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36429782 |
| 160 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32707217 |
| 161 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30993582 |
| 162 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28155722 |
| 163 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26823568 |
| 164 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23282788 |
| 165 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22097111 |

